LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
64 hedge funds and large institutions have $82.1M invested in La Jolla Pharmaceutical Company in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 26 reducing their positions, and 16 closing their positions.
Holders
64
Holders Change
-12
Holders Change %
-15.79%
% of All Funds
1.29%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
4
Increased
17
Reduced
26
Closed
16
Calls
$235K
Puts
$375K
Net Calls
-$140K
Net Calls Change
-$74K
Top Buyers
1 |
TCM
1
Tang Capital Management
San Diego,
California
|
$37.9M |
2 |
2
D.E. Shaw & Co
New York
|
$927K |
3 |
3
Morgan Stanley
New York
|
$3.61M |
4 |
![]()
4
Alyeska Investment Group
Chicago,
Illinois
|
$1.98M |
5 |
5
Goldman Sachs
New York
|
$522K |